Roche NimbleGen reports that Atlas Biolabs, a Berlin-based company, has officially become a certified service provider for NimbleGen Sequence Capture. It will provide services for NimbleGen 454 optimized sequence capture arrays, coupled with sequencing services on the Genome Sequencer FLX System from 454 Life Sciences, a Roche company.


Atlas Biolabs will process customer gDNA samples for genomic enrichment, using the complete NimbleGen sequence capture workflow optimized for 454 GS FLX Titanium Series sequencing using 385K arrays (capture of up to 5 Mb custom regions) and 2.1M arrays (human exome and capture of up to 30 Mb custom regions).

Previous articlePhylogica Taps Isogenica’s In Vitro Display Technology
Next articleRoche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discovery